The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted healthcare providers and members of the public over the circulation of counterfeit Augmentin 625mg Tablets in Nigeria.
In a public alert tagged “Public Alert No. 024/2026,” the agency disclosed that the falsified product is being circulated in packs of 2 x 7 tablets bearing Batch No. AC3N.
According to NAFDAC, the alert followed information received from GlaxoSmithKline (GSK), the Marketing Authorisation Holder for Augmentin products in Nigeria, after a series of complaints about suspected counterfeit versions of the antibiotic surfaced in the country.
The agency stated that GSK confirmed the product as counterfeit after reviewing documentary evidence, photographs, and videos circulating on social media.
Although the fake product carried the same batch number as authentic stock previously supplied to Nigeria, investigations revealed inconsistencies in the manufacturing and expiry dates, confirming that the medicine had been falsified.
Findings from the manufacturer showed that the genuine Batch AC3N was produced at GSK’s Worthing facility in the United Kingdom on August 23, 2023, and packaged between September 19 and 20, 2023.
However, the counterfeit samples were labelled with manufacturing and expiry dates of September 2025 and September 2028 respectively — dates which GSK said do not exist in its production records.
The investigation also identified packaging irregularities, including textual errors and poor-quality sealing, further confirming the products as fake.
NAFDAC warned that Augmentin, which contains amoxicillin and clavulanic acid, is an antibiotic used in the treatment of bacterial infections, stressing that counterfeit versions may contain harmful substances, wrong quantities of active ingredients, or no active ingredients at all.
The agency advised healthcare professionals and medicine distributors to immediately inspect their stocks, quarantine any suspected counterfeit products, and discontinue their sale or distribution.
NAFDAC also urged the public to report any suspected falsified medicines or medical devices to the nearest NAFDAC office, call its toll-free number 0800-162-3322, or send complaints via email to sf.alert@nafdac.gov.ng.
